Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

Epidermal growth factor receptor (EGFR) exon 19 deletion (E19del) is the most common activating mutation in advanced non–small cell lung cancer (NSCLC) and associates with the sensitivity of EGFR tyrosine kinase inhibitors (TKIs) treatment. However, not all mutant patterns of E19del have been well s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Xu, Chun-wei, Lei, Lei, Wang, Wen-xian, Lin, Li, Zhu, You-cai, Wang, Hong, Miao, Li-yun, Wang, Li-ping, Zhuang, Wu, Fang, Mei-yu, Lv, Tang-feng, Song, Yong
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2020
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264750/
https://ncbi.nlm.nih.gov/pubmed/32492620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100791
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados